Search Results - "KNOPF, Kevin"

In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes by Knopf, Kevin M, Murphy, Brendan L, MacMillan, Samantha N, Baskin, Jeremy M, Barr, Martin P, Boros, Eszter, Wilson, Justin J

“…Seven rhenium­(I) complexes of the general formula fac-[Re­(CO)3(NN)­(OH2)]+ where NN = 2,2′-bipyridine (8), 4,4′-dimethyl-2,2′-bipyridine (9),…”
Get full text

An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency by Bennett, Andrew C, Bennett, Charles L, Witherspoon, Bartlett J, Knopf, Kevin B

“…: Ciprofloxacin, levofloxacin, and moxifloxacin belong to the fluoroquinolone class of antibiotics and are amongst the most commonly prescribed antibiotics. In…”
Get more information

In Vivo Anticancer Activity of a Rhenium(I) Tricarbonyl Complex by Konkankit, Chilaluck C, King, A. Paden, Knopf, Kevin M, Southard, Teresa L, Wilson, Justin J

“…The rhenium­(I) complex fac-[Re­(CO)3(2,9-dimethyl-1,10-phenanthroline)­(OH2)]+ (1) was previously shown to exhibit potent in vitro anticancer activity in a…”
Get full text

Intention to probe into the colonoscopy trial: is it the procedure or the trial that failed? by Knopf, Kevin B., Gyawali, Bishal

Get full text

End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia by Hoque, Shamia, Chen, Brian J, Schoen, Martin W, Carson, Kenneth R, Keller, Jesse, Witherspoon, Bartlett J, Knopf, Kevin B, Yang, Y. Tony, Schooley, Benjamin, Nabhan, Chadi, Sartor, Oliver, Yarnold, Paul R, Ray, Paul, Bobolts, Laura, Hrushesky, William J, Dickson, Michael, Bennett, Charles L

“…Erythropoisis stimulating agent (ESA) use was addressed in Food and Drug Administration (FDA) Oncology Drug Advisory Committee (ODAC) meetings between 2004 and…”
Get full text

High Compliance With Choosing Wisely Breast Surgical Guidelines at a Safety-Net Hospital by Tang, Annie, Mooney, Colin M., Mittal, Ananya, Dzubnar, Jessica M., Knopf, Kevin B., Khoury, Amal L.

“…Professional organizations recently set guidelines for avoiding surgeries of low utility and overutilization for the Choosing Wisely campaign. These include…”
Get full text

Factors delaying chemotherapy in patients with breast cancer at a safety-net hospital by Tang, Annie, Mittal, Ananya, Mooney, Colin M, Khoury, Amal L, Chiang, Anna, Lai, Nicole, Knopf, Kevin B

“…Despite advances in healthcare and improved chemotherapy, disparities in breast cancer outcomes continue to persist. Our aim was to evaluate socioeconomic…”
Get full text

Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions by Bennett, Charles L, Schooley, Benjamin, Taylor, Matthew A, Witherspoon, Bartlett J, Godwin, Ashley, Vemula, Jayanth, Ausdenmoore, Henry C, Sartor, Oliver, Yang, Y Tony, Armitage, James O, Hrushesky, William J, Restaino, John, Thomsen, Henrik S, Yarnold, Paul R, Young, Terence, Knopf, Kevin B, Chen, Brian

“…Oncology-associated adverse drug/device reactions can be fatal. Some clinicians who treat single patients with severe oncology-associated toxicities have…”
Get full text

Health Equity Within Inequity: Timing of Diagnostic Breast Cancer Care in an Underserved Medical Population by TANG, ANNIE, MOONEY, COLIN M., BEATTIE, GENNA, COHAN, CAITLIN M., KNOPF, KEVIN B., HARPER, ZHONNET, UGARTE, SHANNON R., KHOURY, AMAL L.

“…Background/Aim: We evaluated timeliness of care at a safety-net hospital after implementation of a multidisciplinary breast program. Patients and Methods: A…”
Get full text

Kilogram-Scale Preparation of an Aminopyrazole Building Block via Copper-Catalyzed Aryl Amidation by Baldwin, Aaron F, Caporello, Michaella A, Chen, Guoyong, Goetz, Adam E, Hu, Weifeng, Jin, Chengfeng, Knopf, Kevin M, Li, Zhifeng, Lu, Cuong V, Monfette, Sebastien, Puchlopek-Dermenci, Angela L. A, Shi, Feng

“…We describe a scalable method for preparing an aminopyrazole building block using copper-catalyzed amidation with acetamide as an ammonia surrogate. This…”
Get full text

End of an era for erythropoiesis‐stimulating agents in oncology by Schoen, Martin W., Hoque, Shamia, Witherspoon, Bartlett J., Schooley, Benjamin, Sartor, Oliver, Yang, Y. Tony, Yarnold, Paul R., Knopf, Kevin B., Hrushesky, William J.M., Dickson, Michael, Chen, Brian J., Nabhan, Chadi, Bennett, Charles L.

“…Erythropoiesis‐stimulating agents (ESAs) are available to treat chemotherapy‐induced anemia (CIA). In 2007–2008, regulatory notifications advised of venous…”
Get full text

Streamlined Synthesis of a Bicyclic Amine Moiety Using an Enzymatic Amidation and Identification of a Novel Solid Form by Brown, Maria S, Caporello, Michaella A, Goetz, Adam E, Johnson, Amber M, Jones, Kris N, Knopf, Kevin M, Kulkarni, Samir A, Lee, Taegyo, Li, Bryan, Lu, Cuong V, Magano, Javier, Puchlopek-Dermenci, Angela L. A, Reyes, Giselle P, Ruggeri, Sally Gut, Wei, Lulin, Weisenburger, Gerald A, Wisdom, Richard A, Zhang, Mengtan

“…We describe a series of improvements to the synthesis of a 3,8-diazabicyclo[3.2.1]­octane derivative that result in a reduced step count and higher overall…”
Get full text

Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL) by Griffiths, Robert, Gleeson, Michelle, Knopf, Kevin, Danese, Mark

“…Diffuse large B-cell lymphoma (DLBCL) comprises 31% of lymphomas in the United States. Although it is an aggressive type of lymphoma, 40% to 50% of patients…”
Get full text

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy‐Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions by Bennett, Charles L., Nagai, Sumimasa, Bennett, Andrew C., Hoque, Shamia, Nabhan, Chadi, Schoen, Martin W., Hrushesky, William J., Luminari, Stefano, Ray, Paul, Yarnold, Paul R., Witherspoon, Bart, Riente, Josh, Bobolts, Laura, Brusk, John, Tombleson, Rebecca, Knopf, Kevin, Fishman, Marc, Yang, Y. Tony, Carson, Kenneth R., Djulbegovic, Benjamin, Restaino, John, Armitage, James O., Sartor, Oliver A.

“…Biosimilars are biologic drug products that are highly similar to reference products in analytic features, pharmacokinetics and pharmacodynamics,…”
Get full text

Primary undifferentiated pleomorphic cardiac sarcoma presenting as right heart failure by Ugarte, Shannon, Sandhu, Rabinder S., Sung, Johnny, Knopf, Kevin B.

“…Right-sided heart failure is a common sequela of left heart failure and seldom presents as a primary disorder. The differential diagnosis of right heart…”
Get full text

Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning by Manak, Michael S., Varsanik, Jonathan S., Hogan, Brad J., Whitfield, Matt J., Su, Wendell R., Joshi, Nikhil, Steinke, Nicolai, Min, Andrew, Berger, Delaney, Saphirstein, Robert J., Dixit, Gauri, Meyyappan, Thiagarajan, Chu, Hui-May, Knopf, Kevin B., Albala, David M., Sant, Grannum R., Chander, Ashok C.

“…The risk stratification of prostate cancer and breast cancer tumours from patients relies on histopathology, selective genomic testing, or on other methods…”
Get full text

Meta-Analysis of the Efficacy and Safety of Bortezomib Re-Treatment in Patients With Multiple Myeloma by Knopf, Kevin B, Duh, Mei Sheng, Lafeuille, Marie-Hélène, Gravel, Jonathan, Lefebvre, Patrick, Niculescu, Liviu, Ba-Mancini, Abbie, Ma, Esprit, Shi, Hongliang, Comenzo, Raymond L

“…Micro-Abstract This meta-analysis of 23 studies of bortezomib-based retreatment in relapsed/refractory myeloma demonstrated a pooled, weighted average response…”
Get full text

The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis by Nordstrom, Beth L., Knopf, Kevin B., Teltsch, Dana Y., Engle, Robert, Beygi, Hooman, Sterchele, James A.

“…Abstract This retrospective study compared adverse-event rates in patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), with and…”
Get full text

Economic Burden of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia by Knopf, Kevin B, Divino, Victoria, McGarry, Lisa, Chen, Yaozhu J, Pokras, Shibani, Munakata, Julie, Taylor, Catherine, Ng, Daniel, Nieset, Christopher, Huang, Hui

“…Micro-Abstract To understand the economic burden of tyrosine kinase inhibitor (TKI) treatment failure in chronic myeloid leukemia (CML), episodes of TKI…”
Get full text

Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis by Divino, Victoria, Karve, Sudeep, Gaughan, Andrew, DeKoven, Mitch, Gao, Guozhi, Knopf, Kevin B, Lanasa, Mark C

“…Describe hairy cell leukemia (HCL) treatment patterns using a large, nationally representative US database. Adults newly diagnosed with HCL (1 January 2006 to…”
Get full text